Albert David Limited (BOM:524075)
India · Delayed Price · Currency is INR 719.25
-5.05 (-0.70%)
At close: Jun 16, 2026
Albert David Market Cap
Albert David has a market cap or net worth of 4.1 billion as of June 16, 2026. Its market cap has decreased by -11.11% in one year.
Market Cap
4.10B
Enterprise Value
1.82B
Revenue
3.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
719.25
Market Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 4.10B, an increase of 5,001.06%. That is a compound annual growth rate of 17.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 4.10B | -2.80% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 6.49B |
| ZIM Laboratories | 5.97B |
| Amanta Healthcare | 5.40B |
| Jenburkt Pharmaceuticals | 5.11B |
| Medico Remedies | 3.49B |
| Trident Lifeline | 2.94B |
| Medicamen Biotech | 2.88B |
| Astonea Labs | 2.82B |